Advertisement

Topics

Companies Related to "Study of TBL 12 Sea Cucumber Extract for Patients With Untreated Asymptomatic Myeloma" [Most Relevant Company Matches] - Page: 4 RSS

12:45 EDT 23rd March 2019 | BioPortfolio

Here are the most relevant search results for "Study of TBL 12 Sea Cucumber Extract for Patients With Untreated Asymptomatic Myeloma" found in our extensive corporate database of over 50,000 company records.

Showing "Study Cucumber Extract Patients With Untreated Asymptomatic Myeloma" Companies 76–100 of 4,300+

Probably Relevant

TABS Group, Inc.

The 2010 TABS Group Vitamin Study was conducted among 1,000 representative respondents aged 18-75 in the TNS panel. The responses were combined with TABS Group's proprietary modeling capabilities to derive the market size estimates for the Vitamin Category. The study was fielded in May 2010, and it replicated a study that was completed in January 2008. TABS Group is a leading provider of resear...


nTouch Research Corporation

nTouch Research Corporation is a leading provider of Phase II-IV clinical trials services delivering investigator selection, patient recruitment and study management services for pharmaceutical, CRO, and biotechnology industries.nTouch owns and operates 16 highly-rated research centers across the USA serving 250 private practice investigators. Our strength is our commitment to sponsors, investigat...

Tensha Therapeutics

Tensha Therapeutics is developing small molecule bromodomain inhibitors, a new class of epigenetic modulators of gene expression, to treat cancer and other serious disorders. The company’s programs are based on the discovery from the laboratory of Dr. James Bradner at Dana-Farber Cancer Institute of first-in-class, potent small molecule BET bromodomain ...


Aterovax SA

Aterovax is developing innovative products for the cardiovascular disease market based on a unique understanding of atherosclerosis, the condition responsible for most cardiovascular problems. Aterovax’s first product is a diagnostic blood test to measure activity of secretory phospholipase A2 (sPLA2), a powerful biomarker that provides physicians wit...

Cellerant Therapeutics Inc.

Cellerant Therapeutics is a clinical stage biotechnology company focused on the regulation of the hematopoietic (blood-forming) system. The Company is developing human stem cell and antibody therapies for oncology applications and blood-related disorders. Cellerant’s lead product, CLT-008 is currently in Phase 1 clinical trials evaluating safety in pa...

NPS Pharmaceuticals, Inc.

NPS Pharmaceuticals is developing new treatment options for patients with rare gastrointestinal and endocrine disorders. The company is currently advancing two Phase 3 registration programs. Teduglutide, a proprietary analog of GLP-2, is being evaluated as GATTEX® in a Phase 3 registration study known as STEPS for intestinal failure associated with shor...

Arno Therapeutics, Inc.

Arno Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops and commercializes innovative products for the treatment of cancer patients. In addition to AR-67, Arno's lead clinical compound is AR-12, a potentially first-in-class, orally available PDK1 inhibitor that blocks the PI3K/Akt pathway and induces autophagy and the endoplasmi...

Cytheris SA

Cytheris is a privately held clinical-stage biopharmaceutical company focused on research and development of therapies for immune modulation.  These drugs aim at reconstituting and enhancing the immune system of patients suffering from cancer, chronic viral or bacterial infections such as HIV, HCV, and HBV or lympho-depleting treatments such as chemotherapy, radiotherapy, bone marrow transp...

Clarient, Inc

Clarient, Inc. is a comprehensive cancer services company and a growing leader in advanced cancer diagnostics. Our Automated Cellular Imaging System ( ACIS ®) has been used to manage more than 200,000 patients. ACIS ® is the only cellular imaging system with broad regulatory clearance and approved for the HER2, ER and PR markers for breast cancer. ACIS ® gives pathologists the confidence of qua...

Evalve, Inc.

Evalve was incorporated in 1999 to design, develop, manufacture and market innovative devices to enable percutaneous repair of cardiac valves. The company’s initial products are intended to reduce the risks, trauma and costs associated with current open, arrested heart surgical options. The company’s present development and clinical efforts are focused on mitral valve repair.An estimated 4 mil...

Vivus

VIVUS, Inc. is a pharmaceutical company dedicated to the development and commercialization of next-generation therapeutic products addressing obesity and sexual health. Analysts speculate that the potential market for obesity ranges from $5 billion to $10 billion annually, and the indications targeted by VIVUS' sexual health products each represent a projected market greater than $1 billion annual...

CollaGenex Pharmaceutical

ollaGenex Pharmaceuticals, Inc. is a pharmaceutical company focused on providing innovative medical therapies for the treatment of periodontitis and other pathologies characterized by the progressive degradation of the body's connective tissues. The Company's core technology involves inhibiting the activity of certain enzymes that degrade such connective tissues. The Company's first...

CBD Pur US

CBD Pur US was the first company to distribute pure CBD isolate internationally and the first to design and formulate water soluble CBD. They grow, extract and formulate pure Pharma Grade quality CBD remaining fully compliant with all Federal regulations.

DeuteRx LLC

DeuteRx is pioneering ‘deuterium-enabled chiral switching’ (DECS), a revolutionary approach to improve racemic (a mixture of two mirror-image compounds or enantiomers) small molecule marketed drugs and drug candidates intended for patients across multiple therapeutic indications. Numerous drugs are still developed and marketed as racemic mixtures...

Okuvision GmbH

Founded by the leaders of Retina Implant AG in 2007, Okuvision GmbH is an innovator in the field of electrical stimulation therapy (EST) for patients with early and intermediate stage retinitis pigmentosa. Building on the lessons learned through the use of Retina Implant’s subretinal implant technology, Okuvision was founded with the goal of testing a...

International Pharmaceutical Research Center

International Pharmaceutical Research Center the commitment to unparalleled Quality Research. Our strength is our recognition from sponsors, investigators, and study subjects in conducting each study with dedication and a personal touch, while maintaining strict compliance with good clinical practice.

&intoconnection

&intoconnection performed a study on what it means for people to be strongly or weakly connected. Due to the international nature of the study, it is not only possible to measure connection by country, but it is also possible to compare connection between countries. The 14 countries studied were China, Japan, the U.S., Russia, Germany, Great Britain, France, Spain, South Africa, Argentina, Isr...

RESprotect GmbH

RESprotect GmbH from Dresden develops drugs that prevent induction of chemoresistance of tumor cells and enhance their chemosensitivity. This concept is worldwide without concurrence. The first drug RP101 significantly extended survival time of pancreas cancer patients in a clinical pilot study.

Genta Incorporated

Genta Incorporated is a biopharmaceutical company with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. Two major programs anchor the Company’s research platform: DNA/RNA-based Medicines and Small Molecules. Genasense® (oblimersen sodium) Injection is the Company's lead com...

BIOCON, INC.

Since 1978 BIOCON has provided highly reliable, custom small animal research services to the region’s leading biomedical scientists. Whether your study involves small animal housing, breeding and colony management, research study applications, safety testing, custom antibody production or fully-compliant Good Laboratory Practices, BIOCON implements our client’s research initiative with dedicat...

Endologix® Inc.

Endologix, Inc. develops and manufactures minimally invasive treatments for aortic disorders. The Company's focus is endovascular stent grafts for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once AAA develops, it continues to enlarge...

Sontra Medical Incorporated

Sontra Medical, Inc., develops ultrasound-based skin permeation technologies and products to extract interstitial fluid for diagnostic purposes and to deliver therapeutics and topical components for pharmaceutical and cosmetic companies

Ischemix, Inc.

Ischemix is a privately-held, clinical-stage pharmaceutical company developing novel cytoprotective compounds for the prevention and treatment of serious diseases and conditions. The initial focus of the Company is the prevention of acute kidney injury and cardiac injury in patients undergoing cardiac catheterization procedures. Ischemix’ lead product...

Corcept Therapeutics

Corcept Therapeutics Incorporated is a pharmaceutical company engaged in the development of drugs for the treatment of severe psychiatric and neurological diseases. Our lead product, CORLUX, is currently in three Phase 3 clinical trials for the treatment of the psychotic features of psychotic major depression (PMD), a disorder that affects approximately three million adults in the United States ea...

B. McLaughlin Associates, Inc.

BMA is a niche provider of clinical research services based in West Chester, Pennsylvania and Phoenix, Arizona. Our services focus on Study Management, Regulatory and Financial Document Retrieval, Clinical Study Agreement/Per Patient Budget Negotiation, Informed Consent Review and Approval, Data Discrepancy Retrieval, and Regulatory Document Audits.


More From BioPortfolio on "Study of TBL 12 Sea Cucumber Extract for Patients With Untreated Asymptomatic Myeloma"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks